|
Name |
4-Isopropyl-6-methyltetralone
|
| Molecular Formula | C14H18O | |
| IUPAC Name* |
6-methyl-4-propan-2-yl-3,4-dihydro-2H-naphthalen-1-one
|
|
| SMILES |
CC1=CC2=C(C=C1)C(=O)CCC2C(C)C
|
|
| InChI |
InChI=1S/C14H18O/c1-9(2)11-6-7-14(15)12-5-4-10(3)8-13(11)12/h4-5,8-9,11H,6-7H2,1-3H3
|
|
| InChIKey |
KIZXBPVAPQXAMH-UHFFFAOYSA-N
|
|
| Synonyms |
57494-10-7; 10-nor-Calamenen-10-one; 4-Isopropyl-6-methyltetral-1-one; 4-Isopropyl-6-methyltetralone; 4-ISOPROPYL-6-METHYL-1-TETRALONE; 10-Norcalamenene-10-one; CHEMBL4090724; DTXSID60423897; E80189; Q67879560; 4-isopropyl-6-methyl-1,2,3,4-tetrahydronaphthalen-1-one
|
|
| CAS | 57494-10-7 | |
| PubChem CID | 6429078 | |
| ChEMBL ID | CHEMBL4090724 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 202.29 | ALogp: | 3.5 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.659 |
| Caco-2 Permeability: | -4.523 | MDCK Permeability: | 0.00001930 |
| Pgp-inhibitor: | 0.555 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.035 |
| 30% Bioavailability (F30%): | 0.934 |
| Blood-Brain-Barrier Penetration (BBB): | 0.971 | Plasma Protein Binding (PPB): | 92.16% |
| Volume Distribution (VD): | 0.529 | Fu: | 7.64% |
| CYP1A2-inhibitor: | 0.36 | CYP1A2-substrate: | 0.93 |
| CYP2C19-inhibitor: | 0.805 | CYP2C19-substrate: | 0.878 |
| CYP2C9-inhibitor: | 0.659 | CYP2C9-substrate: | 0.823 |
| CYP2D6-inhibitor: | 0.056 | CYP2D6-substrate: | 0.673 |
| CYP3A4-inhibitor: | 0.3 | CYP3A4-substrate: | 0.584 |
| Clearance (CL): | 6.995 | Half-life (T1/2): | 0.162 |
| hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.206 |
| Drug-inuced Liver Injury (DILI): | 0.426 | AMES Toxicity: | 0.261 |
| Rat Oral Acute Toxicity: | 0.141 | Maximum Recommended Daily Dose: | 0.188 |
| Skin Sensitization: | 0.044 | Carcinogencity: | 0.431 |
| Eye Corrosion: | 0.013 | Eye Irritation: | 0.324 |
| Respiratory Toxicity: | 0.633 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001822 | ![]() |
0.547 | D06GIP | ![]() |
0.373 | ||
| ENC001821 | ![]() |
0.547 | D0J6WW | ![]() |
0.282 | ||
| ENC002065 | ![]() |
0.527 | D00IUG | ![]() |
0.269 | ||
| ENC004006 | ![]() |
0.508 | D06IXT | ![]() |
0.261 | ||
| ENC006141 | ![]() |
0.453 | D02LZB | ![]() |
0.247 | ||
| ENC000165 | ![]() |
0.429 | D00ZFP | ![]() |
0.241 | ||
| ENC006142 | ![]() |
0.389 | D0EL2O | ![]() |
0.240 | ||
| ENC004005 | ![]() |
0.379 | D01JMC | ![]() |
0.238 | ||
| ENC006050 | ![]() |
0.375 | D01PJR | ![]() |
0.238 | ||
| ENC001355 | ![]() |
0.370 | D05VIX | ![]() |
0.236 | ||